BDSX Biodesix, Inc.

Biodesix is a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. We strive to be a trusted partner that the world relies on for diagnostic solutions in lung disease by improving overall patient outcomes and lowering the overall healthcare cost by reducing the use of ineffective and unnecessary treatments and procedures.

$1.25  -0.02 (-1.58%)
As of 10/03/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/28/2020
Outstanding shares:  39,982,048
Average volume:  253,981
Market cap:   $50,777,201
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMWXS28
Valuation   (See tab for details)
PE ratio:   -0.97
PB ratio:   5.12
PS ratio:   3.69
Return on equity:   -665.52%
Net income %:   -376.01%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy